Whitehawk Therapeutics Inc$1.61 %
Analyst Rating: Hold
Stock Details
CEO
David J. Lennon
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
40
Address
17383 Sunset Blvd, Suite A250, Pacific Palisades, CA, 90272
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Whitehawk Therapeutics Inc $1.61
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results